- Home
- RCKT vs LSAK Comparison
RCKT vs LSAK Comparison
Compare RCKT & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- LSAK
- Stock Information
- Founded
- RCKT 1999
- LSAK 1997
- Country
- RCKT United States
- LSAK South Africa
- Employees
- RCKT N/A
- LSAK N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- RCKT Health Care
- LSAK Finance
- Exchange
- RCKT Nasdaq
- LSAK Nasdaq
- Market Cap
- RCKT 328.6M
- LSAK 344.5M
- IPO Year
- RCKT N/A
- LSAK N/A
- Fundamental
- Price
- RCKT $3.28
- LSAK $4.74
- Analyst Decision
- RCKT Buy
- LSAK
- Analyst Count
- RCKT 13
- LSAK 0
- Target Price
- RCKT $12.96
- LSAK N/A
- AVG Volume (30 Days)
- RCKT 6.0M
- LSAK 18.6K
- Earning Date
- RCKT 08-07-2025
- LSAK 09-10-2025
- Dividend Yield
- RCKT N/A
- LSAK N/A
- EPS Growth
- RCKT N/A
- LSAK N/A
- EPS
- RCKT N/A
- LSAK N/A
- Revenue
- RCKT N/A
- LSAK $574,080,000.00
- Revenue This Year
- RCKT N/A
- LSAK $1.06
- Revenue Next Year
- RCKT $108.43
- LSAK $13.32
- P/E Ratio
- RCKT N/A
- LSAK N/A
- Revenue Growth
- RCKT N/A
- LSAK 4.13
- 52 Week Low
- RCKT $2.19
- LSAK $3.39
- 52 Week High
- RCKT $22.01
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- RCKT 51.17
- LSAK 51.59
- Support Level
- RCKT $2.88
- LSAK $4.60
- Resistance Level
- RCKT $3.74
- LSAK $4.76
- Average True Range (ATR)
- RCKT 0.27
- LSAK 0.11
- MACD
- RCKT 0.02
- LSAK -0.01
- Stochastic Oscillator
- RCKT 35.43
- LSAK 36.73
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.